. Metabolites detected in less than 20% of the male and female cohorts. 2-hydroxy-sebacate 0 (5) 0 (1) 0 (1) 0 (4) 0 (3) 0 (1) 0 (3) 0 (0) 7.9-4.3 2-keto-3-methylvalerate 0 (2) 0 (4) 0 (1) 0 (6) 0 (4) 0 (4) 0 (3) 0 (2) 6.6-11.5 2-keto-isovalerate 0 (1) 0 (1) 0 (0) 0 (1) 0 (0) 0 (0) 0 (0) 0 (1) 0.66-2.1 2-methylbutyrylglycine 0 (0) 0 (3) 0 (0) 0 (0) 0 (1) 0 (1) 0 (3) 0 (9) 2.6-9.3 3-hydroxy-3methyl-glutarate 0 (2) 0 (0) 0 (0) 0 (2) 0 (2) 0 (1) 0 (0) 0 (0) 2.6-3.6 3-hydroxy-dodecanoate 0 (0) 0 (0) 0 (0) 0 (2) 0 (0) 0 (1) 0 (0) 0 (2) 0-3.6 3-hydroxy-butyrate 0 (4) 0 (7) 0 (7) 0 (8) 0 (8) 0 (5) 0 (6) 0 (3) 16.4-16.5 3-hydroxy-valerate 0 (1) 0 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.7-0.4 3-methylcrotonylglycine 0 (0) 0 (3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (1) 0 (0) 0.7-2.1 4-hydroxy-butyrate 0 (0) 0 (0) 0 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.7-0 4-hydroxy-phenylpyruvate 0 (8) 0 (4) 0 (2) 0 (5) 0 (6) 0 (7) 0 (4) 0 (9) 13.1-17.9 5-hydroxy-indoleacetate 7-26.6 Values (mmol/mol creatinine) are expressed as median value; in round brackets the number of subject in which the metabolite was detected; %M-F represents the percentage calculated on the total of male and female populations, respectively. 0.0 (0-0.4) 0.0 (0-0.9) 0.0 (0-3.5) 0.0 (0-2.8) 0.022 None 2-hydroxy-glutarate 2.6 (1.0-4.0) 2.1 (1.0-3.7) 2 (1.7-2.9) 
